CISPLATIN
UC-0120/1004
Phase 3 small_molecule active
Quick answer
CISPLATIN for Ovarian epithelial cancer : intraperitoneal resectable relapse is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Ovarian epithelial cancer : intraperitoneal resectable relapse
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active